Triangle Business Journal reports the North Carolina firm pulled its compounded GLP-1 product after coming under scrutiny.
Recap by typeshit. Post by Triangle Business Journal on X.
He describes a case where a product sourced from neither Eli Lilly nor a compounding pharmacy was followed by liver failure within six days.
The pharmacists' group says the drug looks promising but urges patients to understand what they risk with unofficial sources, and points to its SafeMedication site.
The pharmacists' group points people to its SafeMedication site for a patient-friendly explainer on retatrutide and why unofficial sources are risky.
He says the woman's retatrutide came from neither Lilly nor a compounding pharmacy, and her liver failed within six days of starting it.
The company-sponsored survey of about 300 users supports plans for Revita, which Fractyl says kept about 80% of lost weight off at six months.
RFK Jr. issued the notice after FDA outside advisers backed the six peptides in a contested July recommendation, BioPharma Dive reports.
Loading…